Elrexfio
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
63539-252 -
Package NDC
63539-252-02 -
Application number
BLA761345 -
SPL ID
e5f013ba-4382-4ce2-8650-2ce23a5aaa5b -
SPL set ID
aa044060-5b4b-4692-bf0f-9a50e140b10e -
UNII
L0HR9A577V -
RxCUI
2644885 -
RxCUI
2644891
What the source publishes
- Labeler
- U.S. Pharmaceuticals
- Active ingredients
- elranatamab-bcmm
- Form
- INJECTION, SOLUTION
- Routes
- SUBCUTANEOUS
- Administrative status
- present-in-source-snapshot
- Marketing status
- BLA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Elrexfio",
"splId": "e5f013ba-4382-4ce2-8650-2ce23a5aaa5b",
"labels": [
{
"setId": "aa044060-5b4b-4692-bf0f-9a50e140b10e",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=aa044060-5b4b-4692-bf0f-9a50e140b10e",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=aa044060-5b4b-4692-bf0f-9a50e140b10e"
}
],
"routes": [
"SUBCUTANEOUS"
],
"labeler": "U.S. Pharmaceuticals",
"finished": true,
"packaging": [
{
"sample": true,
"description": "1 VIAL, SINGLE-DOSE in 1 CARTON (63539-252-02) / 1.1 mL in 1 VIAL, SINGLE-DOSE (63539-252-01)",
"package_ndc": "63539-252-02",
"identifierStatus": "well-formed",
"marketing_start_date": "20230815"
}
],
"productId": "63539-252_e5f013ba-4382-4ce2-8650-2ce23a5aaa5b",
"useDomain": "unknown",
"dosageForm": "INJECTION, SOLUTION",
"productNdc": "63539-252",
"deaSchedule": null,
"genericName": "elranatamab-bcmm",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "ELRANATAMAB",
"strength": "44 mg/1.1mL"
}
],
"applicationNumber": "BLA761345",
"marketingCategory": "BLA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20230815",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"unii": [
"L0HR9A577V"
],
"rxcui": [
"2644885",
"2644891"
],
"spl_set_id": [
"aa044060-5b4b-4692-bf0f-9a50e140b10e"
],
"manufacturer_name": [
"U.S. Pharmaceuticals"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:63539-252_e5f013ba-4382-4ce2-8650-2ce23a5aaa5b"